Inovio Pharmaceuticals, Inc. (INO)
NASDAQ·Healthcare·Biotechnology
$1.12
+1.82%
Mkt Cap $62.70M
Analyst Ratings
Buy
0
Hold
1
Sell
0
Price Target (6 analysts)
$2.50
Range $2.50 – $2.50
Implied Upside
+123.2%
Consensus $2.50 vs current $1.12
NASDAQ·Healthcare·Biotechnology
$1.12
+1.82%
Mkt Cap $62.70M
Buy
0
Hold
1
Sell
0
Price Target (6 analysts)
$2.50
Range $2.50 – $2.50
+123.2%
Consensus $2.50 vs current $1.12